ω-3 polyunsatured fatty acids role in postmyocardial infarction therapy

Panminerva Medica

Volumn 45, Issue 2, 2003, Pages 99-107

  Imazio, M ^a   Forno, D ^a   Quaglia, C ^a   Trinchero, R ^a  

^a MARIA VITTORIA HOSPITAL   (Italy)

Author keywords

Diet; Fatty acids, unsatured; Myocardial infarction, prevention and control

Indexed keywords

OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; ANTIARRHYTHMIC AGENT;

ACUTE HEART INFARCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIETARY INTAKE; HEART PROTECTION; HUMAN; LEUKOCYTE; REVIEW; SECONDARY PREVENTION; THROMBOCYTE MEMBRANE; ANIMAL; HEART INFARCTION; METABOLISM;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; FATTY ACIDS, OMEGA-3; HUMANS; MYOCARDIAL INFARCTION;

EID: 0141595937     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. Bang HO, Dyerberg J, Hjhorne N. The composition of food consumed by Greenland Eskimos. Acta Med Scand 1976;200:69-73.
2. Bang HO, Dyerberg J, Sinclair HM. The composition of the Eskimo food in North Western Greenland. Am J Clin Nutr 1980;33:2657-61.
3. Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atheroscerosis. Lancet 1978;2:117-9.
4. Rissanen T, Voutilainen S, Nyyssonen K, Lakka TA, Salonen JT. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acids, and the risk of acute coronary events. The Kuopio Ischemic Heart Disease Risk Factor study. Circulation 2000;102:2677-9.
5. Harper CR, Jacobson TA. The fats of life. The role of ω-3 fatty acids in the prevention of coronary heart disease. Arch Intern Med 2001;161:2185-92.
6. De Caterina R, Madonna R. Antiarrhythmia effects of ω-3 fatty acids. A review. Ital Heart J 2002;3 Suppl 3:297-308.
7. Leaf A, Weber P. A new era for the science in nutrition. Am J Clin Nutr 1987;45:1048-53.
8. Crawford MA. Background to essential fatty acids and their prostanoid derivates. Br Med Bull 1983;39:210-3.
9. Fisher S, Weber PC. Tromboxane A3 is formed in human platelet after dietary eicosapeantaenoic acid. Biochem Biophys Res Commun 1983;116:1091-9.
10. Von Schacky C, Weber PC. Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans. J Clin Invest 1985;76:2446-50.
11. Grey AB, Stapleton JP, Evans MC, Reid IR. The effect of the anti-estrogen tamoxifen on cardiovascular risk factors in normal postmenopausal women. J Clin Endocrinol Metab 1995;80:3191-5.
12. Nestel P, Connor WE, Reardon MF, Connor S, Wong S, Boston R. Suppression by diets rich in fish oil of very low density lipoprotein production in man. J Clin Invest 1984;74:82-9.
13. Harris WS, Connor WE, Illingworth DR, Rothrock DW, Foster DM. Effects of fish oil on VLDL triglyceride kinetics in humans. J Lipid Res 1990;31:1549-58.
14. Sullivan DR, Sanders TA, Trayner IM, Thompson GR. Paradoxical elevation of LDL apoprotein B levels in hypertriglyceridaemic patients and normal subjects ingesting fish oil. Atherosclerosis 1986;61: 129-34.
15. Abbey M, Clifton P, Kestin M, Belling B, Nestel P. Effect of fish oil on lipoproteins, lecithin: cholesterol acyltransferase, and lipid transfer protein activity in humans. Arteriosclerosis 1990;10:85-94.
16. Mori TA, Burke V, Puddey IB, Watts GF, O'Neal DN, Best JD et al. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 2000;71: 1085-94.
17. Contacos C, Barter PJ, Sullivan DR. Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia. Arterioscler Thromb 1993;13:1755-62.
18. Suzukawa M, Abbey M, Howe PR, Nestel PJ. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J Lipid Res 1995;36:473-84.
19. Patti L, Maffettone A, Iovine C, Marino LD, Annuzzi G, Riccardi G et al. Long-term effects of fish oil on lipoprotein subfractions and low density lipoprotein size in non-insulin-dependent diabetic patients with hypertriglyceridemia. Atherosclerosis 1999;146:361-7.
20. Bucher HC, Hengstler P, Schindler C, Meier G. ω-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002;112:298-304.
21. Goodfellow J, Bellamy MF, Ramsey MW, Jones CJ, Lewis MJ. Dietary supplementation with marine ω-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol 2000;35:265-70.
22. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC et al. Blood levels of long-chain ω-3 fatty acids and the risk of sudden death. N Engl J Med 2002;346:1113-8.
23. Lorenz R, Spengler U, Fisher S, Duhm J, Weber PC. Platelet function, thromboxane formation and blood pressure control during supplementation of the Western diet with cod liver oil. Circulation 1983;67:504-11.
24. Vekstein VI, Yeung AC, Vita JA, Nabel EG, Fish RD, Bittl JA et al. Fish oil improves endotelium-dependent relaxations in patients with coronary artery disease. Circulation 1989;80 Suppl 2:II-434.
25. Meydani SN, Lichtestein AH, Cornwall S, Meydani M, Goldin BR, Rasmussen H et al. Immunologic effects of national cholesterol education panel step-2 diets with and without fish-derived ω-3 fatty acid enrichment. J Clin Invest 1993;92:105-13.
26. Radack K, Deck C, Huster G. Dietery supplementation with low-dose fish oils lowers fibrinogen levels: a randomized, double-blind controlled study. Ann Intern Med 1989;111:757-8.
27. Hostmark AT, Bjerkedal T, Kierulf P, Flaten H, Hulshagen K. Fish oil and plasma fibrinogen. BMJ 1988;297:180-1.
28. Sanders TAB, Vickers M, Haines AP. Effects on blood lipids and haemostasis of a supplement of cod-liver oil, rich in eicosapentaenoic and decosahexaenoic acids, in healthy young men. Clin Sci 1981; 61:317-24.
29. Rogers S, James KS, Butland BK, Etherington MD, O'Brien JR, Jones JG. Effects of a fish oil supplement on serum lipids, blood pressure, bleeding time, haemostatic and rheological variables. A double blind randomised controlled trial in healthy volunteers. Atherosclerosis 1987;63:137-43.
30. Stoffersen E, Jorgensen KA, Dyerberg J. Antithrombin III and dietary intake of polyunsaturated fatty acids. Scand J Clin Lab Invest 1982; 42:83-6.
31. Terano T, Hirai A, Hamazaki T, Kobayashi S, Fujita T, Tamura Y et al. Effect of oral administration of higly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. Atherosclerosis 1983;46:321-31.
32. Ernst E. Effects of ω-3 fatty acids on blood rheology. J Intern Med 1989;225 Suppl I:129-32.
33. Morris MC, Sacks F, Rosner B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993;88:523-33.
34. Appel LJ, Miller ER 3d, Seidler AJ, Whelton PK. Does supplementation of diet with "fish oil" reduce blood pressure? A meta-analysis of controlled clinical trials. Arch Intern Med 1993;153:1429-38.
35. Simopoulus AP. ω-3 fatty acids in health and disease and growth and development. Am J Clin Nutr 1991;54:438-53.
36. Seed M, Hoppichler F, Reaveley D, McCarthy S, Thompson GR, Boerwinkle E et al. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med 1990;322:1494-9.
37. Wiklund O, Angelin B, Olofsson SO, Eriksson M, Fager G, Berglund L et al. Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia. Lancet 1990;335:1360-3.
38. Leeson CPM, Mann A, Kattenhorn M, Deanfield JE, Licas A, Muller DPR. Relationship between circulating ω-3 fatty acid concentrations and endothelial function in early adulthood. Eur Heart J 2002;23:216-22.
39. Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 1989;23:12-8.
40. Clarkson P, Celermajer DS, Donald AE, Sampson M, Sorensen KE, Adams M et al. Impaired vascular reactivity in insulin dipendent diabetes mellitus is related to disease duration and low densiy lipoprotein cholesterol levels. J Am Coll Cardiol 1996;28:573-9.
41. Billman GE, Kang JX, Leaf A. Prevention of sudden cardiac death by dietary pure ω-3 polyunsaturated fatty acids in dogs. Circulation 1999;99:2452-7.
42. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312:1205-9.
43. Dolecek TA. Epidemiological evidence of relationships between polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial. Proc Soc Exp Biol Med 1992;200:177-82.
44. Daviglus ML, Stamler J, Orencia AJ, Dyer AR, Liu K, Greenland P et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997;336:1046-53.
45. Albert CM, Hennekens CH, O'Donnell CJ, Ajani UA, Carey VJ, Willett WC et al. Fish consumption and risk of sudden death. JAMA 1998;279:65-6.
46. Harper CR, Jacobson TA. The fats of life. The role of omega-3 fatty acids in the prevention of coronary heart disease. Arch Intern Med 2001;161:2185-92.
47. Dietary supplementation with ω-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 1999;354:447-55.
48. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R et al. Early protection against sudden death by ω-3 polyunsaturated fatty acids after myocardial infarction. Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002;105: 1897-903.
49. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC et al. Blood levels of long-chain ω-3 fatty acids and the risk of sudden death. N Engl J Med 2002;346:1113-8.
50. Christensen JH, Skou HA, Fog L, Hansen V, Vesterlund T, Dyerberg J et al. Marine ω-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation 2001;103:651-7.
51. McLennan PL, Bridle TM, Abeywardena MY, Charnock JS. Comparative efficacy of ω-3 and ω-6 polyunsatured fatty acids in modulating ventricular fibrillation threshold in marmoset monkeys. Am J Clin Nutr 1993;58:666-9.
52. Leaf A, Kang JX. Prevention of cardiac sudden death by ω-3 fatty acids: a review of the evidence. J Intern Med 1996;240:5-12.
53. Schectman G, Kaul S, Cherayil GD, Lee M, Kissebah A. Can the hypotriglyceridemic effect of fish oil concentrate be sustained? Ann Intern Med 1989;110:346-52.
54. Brown JE, Wahle KW. Effect of fish oil and vitamin E supplementation on lipid peroxidation and whole blood aggregation in man. Clin Chim Acta 1990;193:147-56.
55. Nair PP, Judd JT, Berlin E, Taylor PR, Shami S, Sainz E et al. Dietary fish oil induced changes in the distribution of α-tocopherol, retinol and carotene in plasma, red blood cells, and platelets: modulation by vitamin E. Am J Clin Nutr 1993;58:98-102.
56. Vessby B, Boberg M. Dietary supplementation with ω-3 fatty acids may impair glucose homeostasis in patients with non-insulin-dependent diabetes mellitus. J Intern Med 1990;228:165-71.
57. Friedberg CE, Janssen MJ, Heine RJ, Grobbee DE. Fish oil and glycemic control in diabetes. A meta-analysis. Diabetes Care 1998;21:494-500.
58. Marchioli R, Schweiger C, Tavazzi L, Valagussa F. Efficacy of ω-3 polyunsatured fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Lipids 2001;36 Suppl:S119-26.
59. Franzosi MG, Brunetti M, Narchioli R, Marfisi RM, Tognoni G, Valagussa F. GISSI-Prevenzione Investigators. Cost-effectiveness analysis of ω-3 polyunsatured fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial. Pharmacoeconomics 2001;19:411-20.
60. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 2002;106:1893-900.
61. Mariotti R, Mauri F, Barsotti A, Mazzotta G. Revisione ed aggiornamento delle linee guida sulla cardiopatia ischemica acuta. Infarto miocardico acuto. It Heart J 2001;2(5 Suppl):510-52.
62. Rodriguez BL, Sharp DS, Abbott RD, Burchfiel CM, Masaki K, Chyou PH et al. Fish intake may limit the increase in risk of coronary heart disease morbidity and mortality among heavy smokers. The Honolulu Heart Program. Circulation 1996;94:952-6.
63. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999;99:779-85.
64. Albert CM, Hennekens CH, O'Donnell CJ, Ajani UA, Carey VJ, Willett WC et al. Fish consumption and risk of sudden cardiac death. JAMA 1998;279:23-8.
65. Siscovick DS, Raghunathan TE, King I, Weinmann S, Wicklund KG, Albright J et al. Dietary intake and cell membrane levels of long-chain v-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995;274:1363-7.
66. Burr ML, Fehily AM, Gilbert JF, Rogers S, Holliday RM, Sweetnam PM et al. Effect of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarcion trial (DART). Lancet 1989;2:757-61.
67. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine ω-3 fatty acids, fish intake and the risk of coronary disease among men. N Engl J Med 1995;332:977-82.
68. Sellmayer A, Witzgal H, Lorenz RL, Weber PC. Effects of dietary fish oil on ventricular premature complexes. Am J Cardiol 1995;76:1670-3.
69. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312:1205-9.
70. Dyer AR, Stamler J, Shekelle RB. Serum cholesterol and mortality from coronary heart disease in young, middle-aged, and older men and women from 3 Chicago epidemiologic studies. Ann Epidemiol 1992;2:51-7.
71. Orencia AJ, Daviglus ML, Dyer AR, Shekelle RB, Stamler J. Fish consumption and stroke in men: 30 year findings of the Chicago Western Electric Study. Stroke 1996;27:204-9.
72. Norell SE, Ahlbom A, Feychting M, Pedersen NL. Fish consumption and mortality from coronary heart disease. BMJ 1986;293:426.
73. Dolecek TA, Grandits G. Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). World Rev Nutr Diet 1991;66:205-16.
74. Vollset SE, Heuch I, Bjelke E. Fish consumption and mortality from coronary heart disease. N Engl J Med 1985;313:820-1.
75. Guallar E, Hennekens CH, Sacks FM, Willett WC, Stampfer MJ. A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians. J Am Coll Cardiol 1995;25:387-94.
76. Albert CM, Hennekens CH, O'Donnell CJ, Ajani UA, Carey VJ, Willett WC et al. Fish consumption and risk of sudden cardiac death. JAMA 1998;279:23-8.
77. Fraser GE, Sabate J, Beeson WL, Strahan TN. A possible protective effect of nut consumption on risk of coronary heart disease: The Adventist Health Study. Arch Intern Med 1992;152:1416-24.
78. Gramenzi A, Gentile A, Fasoli M, Negri E, Parazzini F, La Vecchia C. Association between certain foods and risk of myocardial infarction in women. Br Med J 1990;330:771-3.
79. Eritsland J, Arnesen H, Gronseth K, Fjeld NB, Abdelnoor M. Effect of dietary supplementation with ω-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol 1996;77:31-6.
80. Nye ER, Ablett MB, Robertson MC, Ilsley CD, Sutherland WH. Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronay angioplasty. Aust N Z J Med 1990;20:549-52.
81. Bairati I, Roy L, Meyer F. Double-blind randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty. Circulation 1992;85:950-6.
82. Gapinski JP, VanRuiswyk JV, Heudebert GR, Schectman GS. Preventing restenosis with fish oils following coronary angioplasty. A meta-analysis. Arch Intern Med 1993;153:1595-601.
83. Bellamy CM, Schofield PM, Faragher EB, Ramsdale DR. Can supplementation of diet with ω-3 polyunsatured fatty acids reduce coronary angioplasty restenosis rate? Eur Heart J 1992;12:1626-31.
84. Johansen O, Brekke M, Seljeflot I, Abdelnoor M, Arnesen H. ω-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial. J Am Coll Cardiol 1999;33:1619-26.
85. Franzen D, Schannwell M, Oette K, Hopp HW. A prospective, randomized, and double-blind trial on the effect of fish oil on the incidence of restenosis following PTCA. Cathet Cardiovasc Diagn 1993;4: 301-10.
86. Arnesen H. ω-3 fatty acids and revascularization procedures. Lipids 2001;36 Suppl:103S-6.
87. Maresta A, Balduccelli M, Varani E, Marzilli M, Galli C, Heiman F et al. Prevention of postcoronary angioplasty restenosis by ω-3 fatty acids: main results of the Esapent for Prevention of Restenosis Italian Study (ESPRIT). Am Heart J 2002;143:E5.
88. Grimminger F, Grimm H, Fuhrer D, Papavassilis C, Lindemann G, Blecher et al. ω-3 lipid infusion in a heart allotransplant model. Shift in fatty acid and lipid mediator profiles and prolongation of transplant survival. Circulation 1996;93:365-71.
89. Andreassen AK, Hartmann A, Offstad J, Geiran O, Kvernebo K, Simonsen S. Hypertension prophylaxis with ω-3 fatty acids in heart transplant recipients. J Am Coll Cardiol 1997;6:1324-31.